| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 24.473 | 77.099 | 100.437 | 85.358 | 106.264 | 124.350 | 143.494 | 165.390 |
| Total Income - EUR | - | - | 24.473 | 77.099 | 100.437 | 85.358 | 106.264 | 124.350 | 143.494 | 165.390 |
| Total Expenses - EUR | - | - | 233 | 5.494 | 7.117 | 7.509 | 5.476 | 6.570 | 13.451 | 14.782 |
| Gross Profit/Loss - EUR | - | - | 24.240 | 71.605 | 93.320 | 77.849 | 100.788 | 117.780 | 130.042 | 150.608 |
| Net Profit/Loss - EUR | - | - | 23.506 | 69.292 | 90.307 | 75.469 | 97.600 | 114.738 | 128.607 | 145.646 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Gammaultramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 15.985 | 12.203 | 8.564 | 5.287 | 2.947 | 587 | 0 |
| Current Assets | - | - | 24.348 | 60.116 | 82.074 | 70.789 | 96.777 | 114.337 | 129.940 | 148.259 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 11 | 1.643 | 1.133 | 82.038 | 4.258 | 1.085 |
| Cash | - | - | 24.348 | 60.116 | 82.063 | 69.146 | 95.643 | 32.299 | 125.682 | 147.174 |
| Shareholders Funds | - | - | 23.550 | 69.343 | 90.358 | 75.519 | 97.649 | 114.787 | 128.656 | 145.694 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 799 | 6.758 | 3.919 | 3.834 | 4.415 | 2.497 | 1.871 | 2.565 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gammaultramed Srl